SCHEMBL21066309

SCHEMBL21066309

Brc1ccc2c3cc4c5ccccc5c5ccccc5c4cc3n(-c3ccccc3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ATM Q13315 1/20 0.50
MAPK1 P28482 1/20 0.39
RXFP1 Q9HBX9 3/20 0.38
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
TSPO P30536 2/20 0.33
MAT2A P31153 3/20 0.33
LIG1 P18858 1/20 0.32
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
RAD52 P43351 1/20 0.32
ACHE P22303 1/20 0.32
HTT P42858 1/20 0.32
PGR P06401 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29793920 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL10018678 0.91 L3MBTL1 (0.50) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL16932046 0.90 L3MBTL1 (0.50) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL29370392 0.89 L3MBTL1 (0.56) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL181585 0.89 L3MBTL1 (0.56) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL21352281 0.88 L3MBTL1 (0.67) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL905051 0.88 L3MBTL1 (0.67) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL17782970 0.86 L3MBTL1 (0.51) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL38661092 0.86 L3MBTL1 (0.53) L3MBTL1KDM4EATMMAPK1RXFP1
SCHEMBL16558195 0.86 L3MBTL1 (0.53) L3MBTL1KDM4EATMMAPK1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109970791-B Indenotriphenylene derivative and organic electroluminescent device using the same 机光科技股份有限公司 2022-07-22 CN disclosed
US-10428269-B2 Indenotriphenylene derivative and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-10-01 US disclosed
US-10428269-B2 Indenotriphenylene derivative and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-10-01 US disclosed
US-20190194534-A1 INDENOTRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-06-27 US disclosed
US-20190194534-A1 INDENOTRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194534-A1 INDENOTRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, INCENP, ITPA L3MBTL1 549/4885KDM4E 1965/4885ATM 2661/4885
US-10428269-B2 Indenotriphenylene derivative and organic electroluminescence device using the same ICMT, INCENP, ITPA L3MBTL1 549/4885KDM4E 1965/4885ATM 2661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.